BioSpring and Phenion receive BMBF-Funding for the development of a bioactive for skin treatment
During the project oligonucleotide molecules will be synthesized and characterized regarding to their biological activity in the skin within the Phenion®-Full Thickness Skin Model. For further development of suitable oligonucleotides the companies will search a strategic partnership e.g. with the pharmaceutical industry.
Most read news
Organizations
Other news from the department science
Get the life science industry in your inbox
By submitting this form you agree that LUMITOS AG will send you the newsletter(s) selected above by email. Your data will not be passed on to third parties. Your data will be stored and processed in accordance with our data protection regulations. LUMITOS may contact you by email for the purpose of advertising or market and opinion surveys. You can revoke your consent at any time without giving reasons to LUMITOS AG, Ernst-Augustin-Str. 2, 12489 Berlin, Germany or by e-mail at revoke@lumitos.com with effect for the future. In addition, each email contains a link to unsubscribe from the corresponding newsletter.